## **Core Concept**
Medullary thyroid carcinoma (MTC) is a type of thyroid cancer that originates from the parafollicular cells, also known as C cells, which produce calcitonin. Unlike other thyroid cancers that arise from follicular cells and can be treated with radioactive iodine, MTC does not respond to radioactive iodine therapy. The primary treatment for MTC involves surgical intervention.

## **Why the Correct Answer is Right**
The correct answer, **Total thyroidectomy**, is the recommended treatment for medullary thyroid carcinoma. This surgical approach aims to remove the entire thyroid gland to eliminate the cancer. In some cases, especially when there's a high risk of recurrence or metastasis, additional treatments such as lymph node dissection may be considered. The goal of surgery is to remove all cancerous tissue while preserving surrounding structures like the parathyroid glands and the recurrent laryngeal nerves.

## **Why Each Wrong Option is Incorrect**
- **Option A: Radioactive iodine therapy** is incorrect because MTC does not take up radioactive iodine due to its origin from C cells, which do not have the ability to uptake iodine.
- **Option B: Chemotherapy** is not the primary treatment for MTC. While chemotherapy may be considered in advanced cases, it is not the first line of treatment.
- **Option C: Radiotherapy** might be used in certain cases, especially for palliation or when there's a high risk of local recurrence, but it is not the primary treatment for MTC.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that patients with medullary thyroid carcinoma often have elevated levels of calcitonin, which can be used as a tumor marker for diagnosis and follow-up. Additionally, multiple endocrine neoplasia type 2 (MEN2), a hereditary condition, is associated with an increased risk of developing MTC, and genetic screening for RET mutations is crucial in the management of MEN2 and familial MTC.

## **Correct Answer:** . Total thyroidectomy